Ads
related to: fda approved new cancer treatment- Request a Rep
Learn More About MYCAPSSA
Schedule a Conversation
- Start Treatment Process
Enroll Your Patients
Download Prescription Form
- Amryt Assist
Patient Services
For You & Your Patients
- Visit Official Site
Oral Octreotide Formulation
watch the Video
- Request a Rep
Search results
Results from the WOW.Com Content Network
(Reuters) -The U.S. Food and Drug Administration on Tuesday approved Johnson & Johnson's chemotherapy-free combination treatment for a type of non-small cell lung cancer, setting up a challenge ...
On Wednesday, the FDA approved Merus N.V.’s (NASDAQ:MRUS) Bizengri (zenocutuzumab-zbco) as the first and only treatment indicated for adults with pancreatic adenocarcinoma or non–small cell ...
The Food and Drug Administration approved the combination therapy of J&J's Rybrevant with carboplatin and pemetrexed for non-small cell lung cancer (NSCLC) patients with a type of mutation in EGFR ...
The U.S. Food and Drug Administration on Thursday granted accelerated approval to Amgen's tarlatamab, a targeted immunotherapy for adults in the advanced stages of hard-to-treat small cell lung ...
Dostarlimab was approved for the treatment of endometrial cancer in both the United States and the European Union in April 2021. [5] [6] [11] [8] [12] Based on the Garnet trial, dostarlimab gained accelerated approval from the US Food and Drug Administration (FDA) in April 2021, [6] and full approval in February 2023. [7]
Irinotecan received accelerated approval from the US Food and Drug Administration (FDA) in 1996, [25] and full approval in 1998. [ 26 ] [ 27 ] [ 28 ] A liposome encapsulated version of irinotecan sold under the brand name Onivyde, was approved by the FDA in October 2015, to treat metastatic pancreatic cancer .
Ads
related to: fda approved new cancer treatment